2 hours ago
Morsa Images
- Roche (RHHBY) has received CE Mark approval for its Elecsys Apolipoprotein E4 biomarker test – the first in-vitro diagnostic (IVD) immunoassay designed to detect the presence of the ApoE4 gene variant in the bloodstream.
- The ApoE4 gene variant is associated with an increased risk of developing Alzheimer's disease and other neurological conditions.
